Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Ending Cash Balance (2009 - 2026)

Updated

Vistagen Therapeutics (VTGN) recorded Ending Cash Balance of $10.89 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 82.7% from $62.79 million a year earlier and down 35.9% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Ending Cash Balance (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics reported Ending Cash Balance of $30.79 million, down 54.1% from FY2025.

  • Annual Ending Cash Balance has a five-year compound annual growth rate of -21.5% (FY2021 to FY2026).
  • Across earlier fiscal years, Ending Cash Balance came in at $67.13 million in FY2025 (-43.7%), $119.17 million in FY2024 (+616.2%), $16.64 million in FY2023 (-75.6%) and $68.14 million in FY2022 (-33.9%).
  • The fiscal Q2 2027 figure is the lowest quarterly Ending Cash Balance since fiscal Q1 2024.
  • On a year-over-year basis, Ending Cash Balance has declined for eight consecutive quarters, with an average decline of 50.2% over the last eight quarters.
  • Peak year-over-year performance for Ending Cash Balance in the last five years was growth of 969.6% in fiscal Q1 2025, against a decline of 82.7% in fiscal Q2 2027 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $16.99 million (Q1 2027), $30.79 million (Q4 2026) and $47.37 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 16,287.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 4.89 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 16.91 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 10.77 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 9.65 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 6.44 Bn
9 Gsk 193.54 Bn 176.38 Bn - 3.88 Bn
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 10.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.89 Mn
Jun 30, 2026 16.99 Mn
Mar 31, 2026 30.79 Mn
Dec 31, 2025 47.37 Mn
Sep 30, 2025 62.79 Mn
Jun 30, 2025 48.99 Mn
Mar 31, 2025 67.13 Mn
Dec 31, 2024 74.72 Mn
Sep 30, 2024 84.25 Mn
Jun 30, 2024 102.92 Mn
Mar 31, 2024 119.17 Mn
Dec 31, 2023 126.56 Mn
Sep 30, 2023 37.61 Mn
Jun 30, 2023 9.62 Mn
Mar 31, 2023 16.64 Mn
Dec 31, 2022 25.04 Mn
Sep 30, 2022 35.29 Mn
Jun 30, 2022 51.99 Mn
Mar 31, 2022 68.14 Mn
Dec 31, 2021 83.70 Mn
API Access

Vistagen Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=VTGN&period=max&api_key=YOUR_API_KEY